Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2
The NM_001346311.2(ATG13):c.1399G>A(p.Gly467Arg) variant causes a missense change. The variant allele was found at a frequency of 0.00884 in 1,613,856 control chromosomes in the GnomAD database, including 137 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
ATG13 (HGNC:29091): (autophagy related 13) The protein encoded by this gene is an autophagy factor and a target of the TOR kinase signaling pathway. The encoded protein is essential for autophagosome formation and mitophagy. [provided by RefSeq, Oct 2016]
Computational evidence support a benign effect (MetaRNN=0.004194081).
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.00736 (1120/152226) while in subpopulation SAS AF= 0.0228 (110/4816). AF 95% confidence interval is 0.0194. There are 11 homozygotes in gnomad4. There are 653 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.